Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS08 - Industry Symposium Sponsored by Janssen Oncology: What the Future Holds for Advanced NSCLC Patients with Resistance to EGFR TKIs

    • 13:00 - 14:00
    • 1/29/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS08.01 - Welcome and Introductions

      13:00 - 13:05  |  Presenter: Tetsuya Mitsudomi

      • Abstract

      No abstract available for this presentation

    • +

      IS08.02 - A Light at the End of the Tunnel - Hope for Patients With EGFR Exon20 Insertion Mutations

      13:05 - 13:25  |  Presenter: Byoung Chul Cho

      • Abstract

      No abstract available for this presentation

    • +

      IS08.03 - The Dawn of a New Era - Novel Treatments for Patients With TKI Resistant Disease With Common EGFR Mutations

      13:25 - 13:45  |  Presenter: Enriqueta Felip

      • Abstract

      No abstract available for this presentation

    • +

      IS08.04 - Live Q&A: From Information to Transformation - Navigating the Evidence With Experience Sharing in a Live Forum to Improve Patient Care

      13:45 - 14:00

      • Abstract

      No abstract available for this presentation

  • +

    IS09 - Industry Symposium Sponsored by Pfizer Oncology: Expert Question Time: ALK+ NSCLC

    • 13:00 - 14:00
    • 1/29/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS09.01 - Welcome and Introduction

      13:00 - 13:05  |  Presenter: Seng Weng Wong

      • Abstract

      No abstract available for this presentation

    • +

      IS09.02 - Navigating Recent Clinical Data for ALK + TKIS

      13:05 - 13:45  |  Presenter: Thanyanan Reungwetwattana

      • Abstract

      No abstract available for this presentation

    • +

      IS09.02 - Selecting Treatment and Management of ALK+ NSCLC

      13:45 - 13:45  |  Presenter: Nick Pavlakis

      • Abstract

      No abstract available for this presentation

    • +

      IS09.02 - The Importance of Managing CNS Disease

      13:45 - 13:45  |  Presenter: John Chang

      • Abstract

      No abstract available for this presentation

    • +

      IS09.02 - The Future of ALK+ NSCLC

      13:45 - 13:45  |  Presenter: Nir Peled

      • Abstract

      No abstract available for this presentation

    • +

      IS09.03 - Q&A

      13:45 - 13:58

      • Abstract

      No abstract available for this presentation

    • +

      IS09.04 - Summary, Thank You and Close

      13:58 - 14:00  |  Presenter: Seng Weng Wong

      • Abstract

      No abstract available for this presentation

  • +

    IS10 - Industry Symposium Sponsored by Bristol Myers Squibb: Thoracic Cancers, New Developments with IO

    • 13:00 - 14:00
    • 1/29/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS10.01 - Welcome and Introductions

      13:00 - 13:05  |  Presenter: Virginie Westeel

      • Abstract

      No abstract available for this presentation

    • +

      IS10.02 - What Is the Role of IO in Non-Metastatic NSCLC?

      13:05 - 13:20  |  Presenter: Virginie Westeel

      • Abstract

      No abstract available for this presentation

    • +

      IS10.03 - IO in the Treatment of Metastatic NSCLC, Where Are We Now?

      13:20 - 13:35  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      IS10.04 - Non-Metastatic and Metastatic NSCLC Q&A

      13:35 - 13:40  |  Presenter: Virginie Westeel, Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      IS10.05 - What Is I-O’s Impact on the Treatment Paradigm for Mesothelioma Patients?

      13:40 - 13:55  |  Presenter: Nicolas Girard

      • Abstract

      No abstract available for this presentation

    • +

      IS10.06 - Mesothelioma Q&A and Closing Remarks

      13:55 - 14:00  |  Presenter: Nicolas Girard, Virginie Westeel

      • Abstract

      No abstract available for this presentation

  • +

    ES05 - Value in Lung Cancer, from Screening to Treatment

    • 14:15 - 15:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Health Services Research/Health Economics
    • +

      ES05.01 - Chair

      14:15 - 14:15  |  Presenter: Antonio Calles

      • Abstract

      No abstract available for this presentation

    • +

      ES05.02 - Chair

      14:15 - 14:15  |  Presenter: Lucinda Morris

      • Abstract

      No abstract available for this presentation

    • +

      ES05.03 - Radiation Oncology: Value and Innovation

      14:15 - 14:25  |  Presenter: Fumiko Ladd Chino

      • Abstract

      Loading...

    • +

      ES05.04 - Lung Cancer Screening in Lower Resource Settings

      14:25 - 14:35  |  Presenter: Ricardo Santos

      • Abstract

      No abstract available for this presentation

    • +

      ES05.05 - Age, Gender and Ethnicity: Disparities in Lung Cancer

      14:35 - 14:45  |  Presenter: Linda Coate

      • Abstract

      No abstract available for this presentation

    • +

      ES05.06 - Molecular Testing, Targeted Agents and Immunotherapy in Lung Cancer: Are They Worth the Cost?

      14:45 - 14:55  |  Presenter: Gilberto Lopes

      • Abstract

      No abstract available for this presentation

    • +

      ES05.07 - Defining Value and Common Sense in Lung Cancer

      14:55 - 15:05  |  Presenter: Bishal Gyawali

      • Abstract

      Loading...

    • +

      ES05.08 - Live Q&A

      15:05 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    ES06 - Perioperative Therapy for Early Stage NSCLC

    • 14:15 - 15:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Early Stage/Localized Disease
    • +

      ES06.01 - Neoadjuvant IO Monotherapy vs. Chemo-IO

      14:15 - 14:30  |  Presenter: Mariano Provencio

      • Abstract

      Loading...

    • +

      ES06.02 - Radiation and IO for Operable Early Stage NSCLC

      14:30 - 14:45  |  Presenter: Suresh Senan

      • Abstract

      Loading...

    • +

      ES06.03 - Neoadjvuant and Adjuvant Targeted Therapies

      14:45 - 15:00  |  Presenter: Wen-zhao Zhong

      • Abstract

      No abstract available for this presentation

    • +

      ES06.04 - MPR and pCR as Primary Endpoints in Neoadjuvant Trials

      15:00 - 15:15  |  Presenter: Noriko Motoi

      • Abstract

      Loading...

  • +

    MA02 - Technological Advances in Diagnostics, Imaging and Therapeutics for Lung Cancer

    • 14:15 - 15:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Diagnostics and Interventional Pulmonology
    • +

      MA02.01 - Chair

      14:15 - 14:15  |  Presenter: Pieter Edsge Postmus

      • Abstract

      No abstract available for this presentation

    • +

      MA02.02 - Chair

      14:15 - 14:15  |  Presenter: David Paul Carbone

      • Abstract

      No abstract available for this presentation

    • +

      MA02.04 - Initial Experience of Hybrid Operating Room Cone-Beam CT Guided Bronchoscopic Microwave Thermal Ablation of Peripheral Small Lung Lesions

      14:15 - 14:20  |  Presenter: Joyce Chan

      • Abstract

      Loading...

    • +

      MA02.05 - NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the US

      14:20 - 14:25  |  Presenter: Erik Folch

      • Abstract

      Loading...

    • +

      MA02.07 - Discussant

      14:25 - 14:30  |  Presenter: Kazuhiro Yasufuku

      • Abstract

      No abstract available for this presentation

    • +

      MA02.08 - Computed Tomography Attenuation Value as Considerable Predictor for Malignancy in Clinical T1 Lung Adenocarcinoma

      14:30 - 14:35  |  Presenter: Zhen-Bin Qiu

      • Abstract

      Loading...

    • +

      MA02.09 - Analysis of Targets for Lung Stereotactic Body Radiotherapy with Clinical Four Dimension (4D) Computed Tomography (CT)

      14:35 - 14:40  |  Presenter: Kaile Li

      • Abstract

      Loading...

    • +

      MA02.10 - Deriving Pulmonary Perfusion Images from 4DCT Using Deep Learning

      14:40 - 14:45  |  Presenter: Daniela Lozano

      • Abstract

      Loading...

    • +

      MA02.11 - Timing and Site-specific Recurrence Pattern for Resected Lung Adenocarcinoma and Association with Driver Gene Mutations

      14:45 - 14:50  |  Presenter: Deng Chaoqiang

      • Abstract

      Loading...

    • +

      MA02.12 - Discussant

      14:50 - 14:55  |  Presenter: Tobias Peikert

      • Abstract

      No abstract available for this presentation

    • +

      MA02.13 - Live Q&A

      14:55 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    ES07 - Pleural Effusion in a Cancer Patient

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Diagnostics and Interventional Pulmonology
    • +

      ES07.01 - Radiological Evaluation of Pleural Effusion in a Cancer Patient

      15:30 - 15:45  |  Presenter: Yeun-Chung Chang

      • Abstract

      Loading...

    • +

      ES07.02 - Role of Pleural Fluid Molecular Markers and PD-L1 Testing

      15:45 - 16:00  |  Presenter: Zoltan Lohinai

      • Abstract

      Loading...

    • +

      ES07.03 - Malignant Pleural Effusion: Patient Presentation and Diagnostic Pathway

      16:00 - 16:15  |  Presenter: Laura McNaughton

      • Abstract

      No abstract available for this presentation

    • +

      ES07.04 - Chemical Pleurodesis, Indwelling Pleural Catheter or Both for Malignant Pleural Effusion

      16:15 - 16:30  |  Presenter: Pyng Lee

      • Abstract

      No abstract available for this presentation

  • +

    MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Early Stage/Localized Disease
    • +

      MA03.01 - Chair

      15:30 - 15:30  |  Presenter: Peter Licht

      • Abstract

      No abstract available for this presentation

    • +

      MA03.02 - Chair

      15:30 - 15:30  |  Presenter: Eric Lim

      • Abstract

      No abstract available for this presentation

    • +

      MA03.03 - Subsolid Lesions Exceeding 3cm: Do the Ground-Glass Opacity Components Still Matter?

      15:30 - 15:35  |  Presenter: fan fan Fan

      • Abstract

      Loading...

    • +

      MA03.04 - Gender-specific Radiomics Models for Predicting Recurrence in Early Stage (Stage I, II) Non-Small Cell Lung Cancer (ES-NSCLC) Patients

      15:35 - 15:40  |  Presenter: Pranjal Vaidya

      • Abstract

      Loading...

    • +

      MA03.05 - Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)

      15:40 - 15:45  |  Presenter: Ray Uyiosa Osarogiagbon

      • Abstract

      Loading...

    • +

      MA03.06 - Health-Related Quality of Life in Lung Cancer Patients Undergoing Thoracic Surgery

      15:45 - 15:50  |  Presenter: Eagan Peters

      • Abstract

      Loading...

    • +

      MA03.07 - Discussant

      15:50 - 15:55  |  Presenter: Wentao Fang

      • Abstract

      No abstract available for this presentation

    • +

      MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

      15:55 - 16:00  |  Presenter: Roxana Reyes

      • Abstract

      Loading...

    • +

      MA03.09 - Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?

      16:00 - 16:05  |  Presenter: Nathaniel Luke Hatton

      • Abstract

      Loading...

    • +

      MA03.10 - Venous Thromboembolism in Lung Cancer Patients: A Population-Based Study

      16:05 - 16:10  |  Presenter: Gilly Akhtar-Danesh

      • Abstract

      Loading...

    • +

      MA03.11 - Cognitive Bias in Lung Cancer Surgery: The Left Digit Effect

      16:10 - 16:15  |  Presenter: Chi-fu Jeffrey Yang

      • Abstract

      Loading...

    • +

      MA03.12 - Discussant

      16:15 - 16:20  |  Presenter: Jay M. Lee

      • Abstract

      No abstract available for this presentation

    • +

      MA03.13 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    OA05 - Value and Quality in Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Health Services Research/Health Economics
    • +

      OA05.01 - Chair

      15:30 - 15:30  |  Presenter: Narjust Duma

      • Abstract

      No abstract available for this presentation

    • +

      OA05.02 - Chair

      15:30 - 15:30  |  Presenter: CS Pramesh

      • Abstract

      No abstract available for this presentation

    • +

      OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study

      15:30 - 15:40  |  Presenter: Abdul Rahman Jazieh

      • Abstract

      Loading...

    • +

      OA05.04 - Clinical and Economic Impact of the Current Testing Scenario for ALK Rearrangements in Spain Compared to a Hypothetical No-Testing Scenario.

      15:40 - 15:50  |  Presenter: Ana Laura Ortega Granados

      • Abstract

      Loading...

    • +

      OA05.05 - Economic Impact of Next-Generation Sequencing (NGS) vs. Single-gene Testing Strategies to Detect Genomic Alterations (GAs) in mNSCLC in Asia

      15:50 - 16:00  |  Presenter: Herbert H Loong

      • Abstract

      Loading...

    • +

      OA05.06 - Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes

      16:00 - 16:10  |  Presenter: Rob G Stirling

      • Abstract

      Loading...

    • +

      OA05.07 - Discussant

      16:10 - 16:20  |  Presenter: Doreen A Ezeife

      • Abstract

      No abstract available for this presentation

    • +

      OA05.08 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    ES08 - The Solitary Pulmonary Nodule

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Diagnostics and Interventional Pulmonology
    • +

      ES08.01 - Chair

      16:45 - 16:45  |  Presenter: Haja Mohideen Salahudeen Mohamed

      • Abstract

      No abstract available for this presentation

    • +

      ES08.02 - Chair

      16:45 - 16:45  |  Presenter: Martin Johnston Phillips

      • Abstract

      No abstract available for this presentation

    • +

      ES08.03 - Evidence Based Evaluation of the Indeterminant Pulmonary Nodule

      16:45 - 16:57  |  Presenter: Annette McWilliams

      • Abstract

      No abstract available for this presentation

    • +

      ES08.04 - Biomarkers in the Evaluation of Pulmonary Nodule

      16:57 - 17:09  |  Presenter: James R Jett

      • Abstract

      Loading...

    • +

      ES08.05 - Targeting the SPN

      17:09 - 17:21  |  Presenter: Kwun Fong

      • Abstract

      No abstract available for this presentation

    • +

      ES08.06 - Bronchoscopic Treatment of SPN: Opportunities and Challenges

      17:21 - 17:33  |  Presenter: David Feller-Kopman

      • Abstract

      No abstract available for this presentation

    • +

      ES08.07 - Live Q&A

      17:33 - 17:45

      • Abstract

      No abstract available for this presentation